Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

May 6, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2029

Conditions
Coronary Artery DiseaseIschemic Heart Disease
Interventions
DEVICE

Supraflex Cruz Sirolimus-eluting Stent

PCI with SupraFlex Cruz® stent in de novo coronary stenosis of patients under chronic oral anticoagulation.

Trial Locations (7)

6800

RECRUITING

Hospital General Universitario de Merida, Badajoz

12004

RECRUITING

Hospital General Universitari de Castelló, Castelló

28222

RECRUITING

Hospital Universitario Puerta de Hierro, Majadahonda

50009

RECRUITING

Hospital Clinico Universitario Lozano Blesa, Zaragoza

02008

RECRUITING

Hospital General Universitario de Albacete, Albacete

03550

RECRUITING

Hospital Universitario San Juan de Alicante, Alicante

03203

RECRUITING

Hospital General Universitari d'Elx, Elche

All Listed Sponsors
lead

Fundación EPIC

OTHER